FIELD: chemistry.
SUBSTANCE: invention describes a compound of formula
or a pharmaceutically acceptable salt thereof, where: R1 is O or F; R3 is H, Me, Et, OH, MeO, EtO-, HOCH2CH2O-, HOCH2C(Me)2O-, (S)-MeCH(OH)CH2O-, (R)-HOCH2CH(OH)CH2O-, cyclopropyl-CH2O-, HOCH2CH2-, , , , , or ; R7 is cyclopropyl-CH2- or C1-C4alkyl, where said alkyl is optionally substituted with one or more F; R8 is Br, I or SMe; and R9 is CH3, CH2F, CHF2, CF3, F or Cl. The invention also discloses use of said compound in preparing a medicinal agent for treating a hyperproliferative disorder or an inflammatory condition, as well as a MEK inhibiting pharmaceutical composition.
EFFECT: novel compounds are obtained and described, which are MEK inhibitors and can useful in treating hyperproliferative diseases such as cancer and inflammation in mammals and inflammatory conditions.
13 cl, 25 ex, 8 tbl, 15 dwg
Title | Year | Author | Number |
---|---|---|---|
HETEROCYCLIC MEK INHIBITORS AND METHODS OF USING THEREOF | 2006 |
|
RU2414455C2 |
PHARMACEUTICAL COMBINATIONS | 2013 |
|
RU2674995C2 |
SYNERGISTIC COMBINATIONS OF PI3K- AND MEK-INHIBITORS | 2012 |
|
RU2607944C2 |
PROPOSED 3,4-DIHYDRO-2,7-NAPHTHYRIDINE-1,6(2H,7H)-DIONES AS MEK INHIBITORS | 2022 |
|
RU2826000C1 |
HETEROCYCLIC MEK INHIBITORS AND METHODS OF APPLICATION | 2004 |
|
RU2351593C2 |
BICYCLIC HETEROCYCLES AS MEK KINASE INHIBITORS | 2009 |
|
RU2509078C2 |
MDM2 INHIBITORS AND COMBINATIONS THEREOF | 2016 |
|
RU2740091C2 |
5-ANILINOIMIDAZOPYRIDINES AND METHODS FOR USING THEM | 2008 |
|
RU2441004C1 |
COMBINATION OF 6-OXO-1,6-DIHYDRO-PYRIDAZINE DERIVATIVE HAVING ANTICOLIC ACTIVITY, WITH MEK INHIBITOR | 2013 |
|
RU2684407C2 |
AZABENZOFURANYL COMPOUNDS AND METHODS OF USE | 2007 |
|
RU2448111C2 |
Authors
Dates
2013-12-10—Published
2006-05-17—Filed